Alembic Pharmaceuticals has received the Food & Drug Administration’s nod for tadalafil tablets. It will be available in dosage strengths of 2.5 mg, 5 mg, 10 mg and 20 mg.
The product is the generic of Eli Lilly’s Cialis tablets.
It is indicated for the treatment of erectile dysfunction. Tadalafil tablet 5 mg strength is additionally indicated for the treatment of signs and symptoms of benign prostatic hyperplasia.
Tadalafil tablets have a market value of $1.8 billion for the twelve months ending December 2018, according to IQVIA.